Date:11/1/2011

ment of asset retirement obligation(124)-Stock-based compensation7,3936,466Accretion of asset retirement obligation27-Amortization of debt discount-70Accretion (amortization) of premium/discount on marketable securities501511Changes in operating assets and liabilities:Accounts receivable(3,991)(8,132)Inventories(2,423)(331)Prepaid expenses and other current assets(844)(213)Other assets202,602Accounts payable(1,699)(1,360)Accrued compensation(1,942)(472)Other accrued liabilities7,355(4,247)Deferred revenues891(9,276)Net cash provided by (used in) operating activities2,406(16,052)Investing activities:(Increase) decrease  in restricted cash(46)65Purchase of property and equipment(7,813)(4,740)Purchase of marketable securities(50,900)(49,051)Proceeds from sale of marketable securities5,0081,605Proceeds from maturities of marketable securities6,50070,696Net cash provided by (used in) investing activities(47,251)18,575Financing activities:Principal payments on financing obligations-(3,979)Payments in preparation for initial public offering-(3,870)Proceeds from issuance of common stock on IPO, net of underwriting discounts-72,551Proceeds from exercises of stock options2,476279Net cash provided by (used in) financing activities2,47664,981Effect of exchange rate changes on cash and cash equivalents105(15)Net increase in cash and cash equivalents(42,264)67,489Cash and cash equivalents:   Beginning of the period72,39631,785   End of the period30,13299,274   Marketable securities at the end of period40,52347,306Cash, cash equivalents and marketable securities$  70,655$ 146,580Reclassification of preferred stock warrant from liability to additional paid-in capital$
2,686Conversion of preferred stock to common stock and additional paid-in capital$ 179,672Reconciliation of GAAP to Non-GAAP Financial InformationIn this press release, in addition to GAAP financial results, we present Adjusted EBITDA because we believe it assists investors and analysts in
'/>"/>

SOURCE Codexis, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. 50 Pharma Companies Worldwide Now Use Codexis In Process Development
2. Codexis Names Veteran Chemical Executive to Lead Codexis do Brasil
3. Codexis, Raizen to Develop First Generation Ethanol
4. Codexis to Present at Three Investor Conferences in September
5. Codexis Presents Carbon Capture Update at DoE/NETL Conference
6. Codexis Board Elects Pedro I. Mizutani, Raizen EVP, as Director
7. Codexis Reports Second Quarter 2011 Results
8. Codexis and Chemtex to Collaborate on Sustainable Detergent Alcohols for the Household Products Market
9. Codexis to Present at the Pacific Crest and Canaccord Genuity Conferences
10. Codexis to Present at 3 Investor Conferences in June
11. Codexis Achieves Development Milestones With Teva